Phathom Pharmaceuticals (PHAT) Cash & Equivalents (2018 - 2026)
Phathom Pharmaceuticals (PHAT) posted Cash & Equivalents of $185.34 million for Q2 2026, up 21.6% from $152.43 million a year earlier and up 0.9% from the prior quarter.
Powered by 
Analysis
Phathom Pharmaceuticals (PHAT) Cash & Equivalents (2018 - 2026) Analysis & Trends
At the end of FY2025, Phathom Pharmaceuticals' Cash & Equivalents came in at $132.83 million, down 55.7% from FY2024.
- Annual Cash & Equivalents shows a five-year compound annual growth rate of -14.3% (FY2020 to FY2025).
- In prior years, Phathom Pharmaceuticals' Cash & Equivalents was $300.13 million in FY2024 (-21.9%), $384.26 million in FY2023 (+146.5%), $155.89 million in FY2022 (-15.0%) and $183.42 million in FY2021 (-36.2%).
- The Q2 2026 figure stands as the highest quarterly Cash & Equivalents since Q1 2025.
- On a year-over-year basis, Cash & Equivalents increased in two of the last eight quarters, with an average decline of 19.1%.
- The strongest year-over-year quarter for Cash & Equivalents in the past five years was Q1 2024, with growth of 149.9%; the weakest was Q3 2025, with a decline of 59.1%.
- According to Business Quant data, Cash & Equivalents for the three prior quarters was $183.77 million (Q1 2026), $132.83 million (Q4 2025) and $138.02 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Phathom Pharmaceuticals | 566.90 Mn | -73.06 Mn | 59.18 Mn | 185.34 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 185.34 Mn |
| Mar 31, 2026 | 183.77 Mn |
| Dec 31, 2025 | 132.83 Mn |
| Sep 30, 2025 | 138.02 Mn |
| Jun 30, 2025 | 152.43 Mn |
| Mar 31, 2025 | 215.18 Mn |
| Dec 31, 2024 | 300.13 Mn |
| Sep 30, 2024 | 337.54 Mn |
| Jun 30, 2024 | 279.10 Mn |
| Mar 31, 2024 | 325.10 Mn |
| Dec 31, 2023 | 384.26 Mn |
| Sep 30, 2023 | 216.54 Mn |
| Jun 30, 2023 | 249.38 Mn |
| Mar 31, 2023 | 130.08 Mn |
| Dec 31, 2022 | 155.89 Mn |
| Sep 30, 2022 | 197.34 Mn |
| Jun 30, 2022 | 207.90 Mn |
| Mar 31, 2022 | 138.60 Mn |
| Dec 31, 2021 | 183.42 Mn |
| Sep 30, 2021 | 224.62 Mn |
API Access
Phathom Pharmaceuticals Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=PHAT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "PHAT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=PHAT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();